发明名称 AZACYCLOALKYL SUBSTITUTED ACETIC ACID DERIVATIVES FOR USE AS MMP INHIBITORS.
摘要 Compounds of the formula (I) wherein R represents OH or NHOH; R1 represents hydrogen, optionally substituted lower alkyl, aryl-lower alkyl, cycloalkyl-lower alkyl, or acyl derived from a carboxylic acid, from a carbonic acid, from a carbamic acid of from a sulfonic acid; R2 represents biarylsulfonyl or aryloxyarylsufonyl; R3 represents hydrogen, optionally substituted lower alkyl, aryl-lower alkyl, cycloalkyl-lower alkyl or acyl derived from a carboxylic acid, from a carbonic acid or form a carbamic acid; R4 and R5 represent independently hydrogen, lower alkyl, lower alkoxycarbonyl, aryl-lower alkyl or cycloalkyl-lower alkyl; m is zero, 1, 2 or 3; pharmaceutically acceptable prodrug derivatives thereof; pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising said compounds; and their use for inhibiting matrix degrading metalloproteinases and preventing or treating matrix metalloproteinase dependent conditions in mammals.
申请公布号 CA2440419(C) 申请公布日期 2010.05.04
申请号 CA20022440419 申请日期 2002.03.13
申请人 NOVARTIS AG 发明人 FUJIMOTO, ROGER AKI;MCQUIRE, LESLIE WIGHTON;MONOVICH, LAUREN G.;NANTERMET, PHILIPPE;PARKER, DAVID THOMAS;ROBINSON, LESLIE ANN;SKILES, JERRY W.;TOMMASI, RUBEN ALBERTO
分类号 C07D211/16;C12N9/99;A61K31/40;A61K31/445;A61K31/4525;A61K31/4535;A61K31/454;A61K31/4545;A61K31/4725;A61K31/496;A61K31/501;A61K31/5377;A61K31/55;A61P1/04;A61P7/00;A61P9/10;A61P11/06;A61P19/02;A61P19/08;A61P19/10;A61P25/00;A61P25/14;A61P27/02;A61P27/06;A61P29/00;A61P35/00;A61P35/04;A61P43/00;C07D211/26;C07D211/32;C07D211/34;C07D401/12;C07D405/12;C07D405/14;C07D409/12;C07D409/14;C07D413/14;C07D417/04;C07D417/12;C07D417/14 主分类号 C07D211/16
代理机构 代理人
主权项
地址